Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 20Prostatic Neoplasms 7Breast Neoplasms 7Head and Neck Neoplasms 6Esophageal Squamous Cell Carcinoma 6Esophageal Neoplasms 6Rectal Neoplasms 4Radiation Injuries 4Carcinoma, Squamous Cell 4Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Nasopharyngeal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Recurrence 2Lung Neoplasms 2Vulvar Neoplasms 1Thyroid Neoplasms 1Sinonasal undifferentiated carcinoma 1Radiation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Obesity 1Neurotoxicity Syndromes 1Neoplasms 1

Interventions

ebselen 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Chemotherapy, Adjuvant 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Ototoxicity × Radiotherapy, Intensity-Modulated × Clear all
NCT01216800 2010-10-07

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
84 enrolled
Head & Neck

Ototoxicity, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡